An Update on Patient-Reported Outcomes in Asthma
CHEST · 2024-05 · 165 (5) · 1049-1057
DOI: 10.1016/j.chest.2024.02.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CHEST, 2024-05. Verfasst von Tianshi David Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston TX; Center for Innovations in Quality, Effectiveness, an…. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Asthma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
TOPIC IMPORTANCE: Patient-reported outcomes (PROs) are information provided by patients on their condition, function, well-being, or experience. Instruments to quantify PROs, called patient-reported outcome measures (PROMs), allow standardized assessment of a unique dimension of health that cannot be measured physically. Herein, we discuss how to appraise PROMs critically and provide an update on their use in asthma clinical practice and research. REVIEW FINDINGS: Asthma-specific PROMs have been developed to measure a wide array of disease characteristics, including symptoms, medication use, exacerbations, and impairments to emotional and physical function. Some PROMs also include spirometry or expand questions to overlap with rhinitis symptoms. Use of PROMs to understand asthma control is included in management guidelines, yet real-world evidence of their effectiveness in improving asthma care remains limited. These instruments may be less accurate in characterizing patients with poorly controlled asthma and have modest correlation with exacerbation risk. Two new PROMs are highlighted, the Asthma Impairment and Risk Questionnaire as an instrument to assess asthma control that incorporates domains related to exacerbation risk and impairment, and the CompEx as a composite of daily diary reporting combined with exacerbation events as an early efficacy signal for interventional trials. SUMMARY: PROMs are fundamental to asthma assessment. Novel instruments may improve the detection of patients at risk for poor outcomes and shorten the drug discovery pipeline. However, urgent research is needed to understand their practical utility in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston TX; Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey VA Medical Center, Houston TX. Electronic…
- Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, Groningen, The Netherlands; Department of Respiratory Medicine & Allergology, Skåne University Hospital, Lund, Sweden.
- Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston TX.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Wu, T. D., Diamant, Z., & Hanania, N. A. (2024). An Update on Patient-Reported Outcomes in Asthma. CHEST, 165(5), 1049-1057. https://doi.org/10.1016/j.chest.2024.02.010
Vancouver
Wu TD, Diamant Z, Hanania NA. An Update on Patient-Reported Outcomes in Asthma. CHEST. 2024;165(5):1049-1057. doi:10.1016/j.chest.2024.02.010
BibTeX
@article{Wu2024,
author = {Wu, Tianshi David and Diamant, Zuzana and Hanania, Nicola A},
title = {An Update on Patient-Reported Outcomes in Asthma},
journal = {CHEST},
year = {2024},
volume = {165},
number = {5},
pages = {1049--1057},
doi = {10.1016/j.chest.2024.02.010}
}
EUVIMED